Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Kruger DF;Kruger DF; Anderson JE; Anderson JE
  • Source:
    Diabetes technology & therapeutics [Diabetes Technol Ther] 2021 Sep; Vol. 23 (S3), pp. S45-S55.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE
    • Publication Information:
      Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c1999-
    • Subject Terms:
      Blood Glucose Self-Monitoring* ; Diabetes Mellitus, Type 2*/drug therapy; Blood Glucose/analysis ; Humans ; Insurance Coverage ; Retrospective Studies ; Reward
    • Abstract:
      Recent studies have demonstrated the clinical utility of continuous glucose monitoring (CGM) use in type 2 diabetes (T2D) patients who are treated with intensive insulin management. Large retrospective database analyses of T2D patients treated with less-intensive therapies have also shown that CGM use was associated with significant reductions in hemoglobin A1c levels and health resource utilization, including diabetes-related hospitalizations and emergency room care. Despite the growing body of evidence supporting CGM use in the broader T2D population, current eligibility criteria required by public and many private insurers are denying millions of individuals with T2D access to this valuable technology. In this article, we discuss an evidence-based rationale for modifying current eligibility requirements for CGM coverage.
    • Contributed Indexing:
      Keywords: Blood glucose monitoring; Continuous Glucose Monitoring; Eligibility criteria; Type 2 diabetes
    • Accession Number:
      0 (Blood Glucose)
    • Publication Date:
      Date Created: 20210623 Date Completed: 20220331 Latest Revision: 20220401
    • Publication Date:
      20240105
    • Accession Number:
      10.1089/dia.2021.0193
    • Accession Number:
      34160300